Category: Infectious Diseases
Infectious Diseases market research reports by GlobalData
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024 provides an overview of Hospital Acquired Pneumonia (HAP) Clinical trials scenario. This report provides top li ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
mRNA Vaccines in Infectious Diseases Market Overview Summary The report provides an assessment of the mRNA vaccines space, including History of mRNA Therapeutics Development, Industry Trends, Marketed Products, Pipeline Product, Opportunities, Challenges, and Unmet Needs, Current Companies and Brief ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hospital Acquired Pneumonia therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
-
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research Summary Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes with the intention of regulating the human microbiome composition in a beneficial way that may ... Read More
-
Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial ... Read More
Research Assistance
